WallStSmart

Humana Inc (HUM)vsViking Holdings Ltd (VIK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Humana Inc generates 1961% more annual revenue ($137.20B vs $6.66B). VIK leads profitability with a 18.0% profit margin vs 0.8%. VIK trades at a lower P/E of 35.3x. VIK earns a higher WallStSmart Score of 57/100 (C).

HUM

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 4.5Value: 5.3Quality: 6.5
Piotroski: 4/9Altman Z: 3.91

VIK

Buy

57

out of 100

Grade: C

Growth: 9.3Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 5/9Altman Z: 0.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HUMUndervalued (+23.7%)

Margin of Safety

+23.7%

Fair Value

$403.67

Current Price

$350.08

$53.59 discount

UndervaluedFair: $403.67Overvalued

Intrinsic value data unavailable for VIK.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HUM4 strengths · Avg: 8.5/10
Altman Z-ScoreHealth
3.9110/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
23.5%8/10

Revenue surging 23.5% year-over-year

Free Cash FlowQuality
$1.13B8/10

Generating 1.1B in free cash flow

VIK3 strengths · Avg: 9.3/10
Return on EquityProfitability
112.4%10/10

Every $100 of equity generates 112 in profit

EPS GrowthGrowth
226.6%10/10

Earnings expanding 226.6% YoY

Revenue GrowthGrowth
17.5%8/10

17.5% revenue growth

Areas to Watch

HUM4 concerns · Avg: 3.3/10
PEG RatioValuation
2.154/10

Expensive relative to growth rate

Return on EquityProfitability
6.1%3/10

ROE of 6.1% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Operating MarginProfitability
4.7%3/10

Operating margin of 4.7%

VIK4 concerns · Avg: 2.8/10
P/E RatioValuation
35.3x4/10

Premium valuation, high expectations priced in

Operating MarginProfitability
1.1%3/10

Operating margin of 1.1%

Price/BookValuation
38.6x2/10

Trading at 38.6x book value

Altman Z-ScoreHealth
0.402/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : HUM

The strongest argument for HUM centers on Altman Z-Score, Price/Book, Revenue Growth. Revenue growth of 23.5% demonstrates continued momentum.

Bull Case : VIK

The strongest argument for VIK centers on Return on Equity, EPS Growth, Revenue Growth. Profitability is solid with margins at 18.0% and operating margin at 1.1%. Revenue growth of 17.5% demonstrates continued momentum.

Bear Case : HUM

The primary concerns for HUM are PEG Ratio, Return on Equity, Profit Margin. A P/E of 40.5x leaves little room for execution misses. Thin 0.8% margins leave little buffer for downturns.

Bear Case : VIK

The primary concerns for VIK are P/E Ratio, Operating Margin, Price/Book.

Key Dynamics to Monitor

VIK carries more volatility with a beta of 1.59 — expect wider price swings.

HUM is growing revenue faster at 23.5% — sustainability is the question.

HUM generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor HEALTHCARE PLANS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VIK scores higher overall (57/100 vs 52/100), backed by strong 18.0% margins and 17.5% revenue growth. HUM offers better value entry with a 23.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Humana Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.

Visit Website →

Viking Holdings Ltd

CONSUMER CYCLICAL · TRAVEL SERVICES · USA

Viking Holdings Ltd engages in the passenger shipping and other forms of passenger transport in North America, the United Kingdom, and internationally. The company is headquartered in Pembroke, Bermuda.

Want to dig deeper into these stocks?